Carregant...
Low-dose subcutaneous immunoglobulin is an effective treatment for autoimmune bullous skin disorders: A case report
Intravenous immunoglobulin is a recognized treatment in recalcitrant autoimmune bullous diseases. Infusions are administered monthly over 1–5 days in the hospital setting and associated with mild to severe infusion-related systemic effects, in part due to the high doses necessary to induce and achie...
Guardat en:
| Publicat a: | SAGE Open Med Case Rep |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SAGE Publications
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6974749/ https://ncbi.nlm.nih.gov/pubmed/32010445 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050313X19901071 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|